Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
30 Jul 2025
• 7 min
• EN
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld. See omnystudio.com/listener for privacy information.
From "Bloomberg Talks"
Listen on your iPhone
Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?
Comments
Add comment Feedback